Fact Sheet

#Cures2015: What They’re Saying


04.30.15

“Potential of being one of the most transformational pieces of legislation… since the National Cancer Act of 1971″

After a year of hard work, the 21st Century Cures legislative chapter is moving forward. The Subcommittee on Health today held a legislative hearing with witnesses from National Institutes of Health and Food and Drug Administraiton to discuss draft legislation that was released on Wednesday.  21st Century Cures has been a truly collaborative effort and the draft is the product of a year of listening to patients and other experts, patient advocate groups and health care organizations continue to express support for the legislation. Former FDA Commissioner and renowned health expert Andrew von Eschenbach commentedI think it has the potential of being one of the most transformational pieces of legislation that has come along since the National Cancer Act of 1971.” See what others are saying below:

“We look forward to working with Chairman Upton, Rep. DeGette and members of the Energy and Commerce Committee to ensure that the 21st Century Cures Initiative expedites the delivery of the next generation of modern medicines that will save lives and reduce and eliminate suffering.”

#Cures2015 draft “reflects the broad bipartisan consensus that the health of our country depends on lifesaving discoveries at institutions including the National Cancer Institute that advance the detection and treatment of chronic diseases such as cancer.”

“We are particularly pleased to see the draft’s emphasis on reducing regulatory barriers that unnecessarily slow clinical trials. We also are very encouraged by the committee’s efforts to increase funding for the National Institutes of Health, which Mayo Clinic believes is an essential national investment.”

“PhRMA applauds the work of Chairman Upton, Congresswoman DeGette, Ranking Member Pallone and members of the Committee for their tireless work to issue the latest Cures draft after a year of working with stakeholders, patient groups and others to accelerate the discovery, development and delivery of new medicines for patients.”

”BPC commends House Energy and Commerce Committee Chairman Fred Upton (R-MI), Ranking Member Frank Pallone, Jr. (D-NJ), Oversight and Investigations Subcommittee Ranking Member Rep. Diana DeGette (D-CO), Health Subcommittee Chairman Joe Pitts (R-PA), and Health Subcommittee Ranking Member Gene Green (D-TX) for their tireless efforts on developing and releasing the bipartisan 21st Century Cures draft legislation… (T)remendous opportunity for providing hope for patients and accelerated progress on research, new medicines and treatments.”

“CHI applauds Chairman Fred Upton (R-Mich.) and Congresswoman Diana DeGette (D-Colo.) for leading this bipartisan, thoughtful approach to spurring scientific discovery that will provide hope for patients and their families while also protecting jobs and America’s leadership role in healthcare innovation.”

“The 21st Century Cures initiative released today includes a number of encouraging ideas on how to advance the development of new medical therapies.  The Committee and its staff deserve praise for efforts to bring these ideas together and for their months of work to make this a collaborative and transparent process. …Nothing is more important to the rare disease community than providing an environment conducive to the development of new therapies and access to them.”

“(R)eflects substantial input from all stakeholders. With expanded support for the National Institutes of Health (NIH), greater sensitivity to the regulatory frameworks of the Food and Drug Administration (FDA), and a clear emphasis on including patients in implementation, it represents an important step forward in the legislative process.”

“Today’s 21st Century Cures hearing continues to drive home the importance of innovation in health care as we all work together toward more cost effective care and improved patient outcomes. Our health care system cannot afford to remain stagnant; the increased funding for the NIH in the 21st Century Cures draft is an important acknowledgment of the need for robust research to generate new and improved ways to treat patients.”

“This is an issue that affects every American family, and the strong bipartisan support for moving forward is heartening.”

“The strong, bipartisan work that has resulted in the latest ‘21st Century Cures’ discussion draft is a testament to the passion of Chairman Upton and Congresswoman DeGette, and every Member of Congress who recognizes the unique role of medical technology innovation.”

Learn more about the Cures initiative here. See what others are saying on Facebook and Twitter using #Cures2015.

###

Fact Sheet